Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Patient Reported Outcome Measures × NET × 90 days × Clear all

Sponsor

Cancer Type

Other neoplasm 2 Other hematologic neoplasm 2 Myeloid 2 Lymphoid 2 Sarcoma 1 Gastrointestinal 1 Breast 1

Interventions

lutetium Lu 177 dotatate 15 Magnetic Resonance Spectroscopy 9 Everolimus 8 Specimen Handling 7 cabozantinib 5 Lutetium-177 5 pembrolizumab 4 X-Rays 4 olaparib 3 lenvatinib 3 gallium Ga 68 dotatate 3 Octreotide 3 Nivolumab 3 Lutetium 3 Fluorodeoxyglucose F18 3 surufatinib 2 pasireotide 2 lanreotide 2 copper dotatate CU-64 2 avelumab 2 atezolizumab 2 Sunitinib 2 Radiotherapy 2 Phantoms, Imaging 2 Ipilimumab 2 Etoposide 2 Cyclophosphamide 2 Cisplatin 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2 tivozanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡